- Home
- Automated
- List of product information
- SELENIUM AGUETTANT CONCENTRATE FOR SOLUTION FOR INFUSION 10 MCG/ML [SIN16847P]
SELENIUM AGUETTANT CONCENTRATE FOR SOLUTION FOR INFUSION 10 MCG/ML [SIN16847P]
Active ingredients: SELENIUM AGUETTANT CONCENTRATE FOR SOLUTION FOR INFUSION 10 MCG/ML
Product Info
SELENIUM AGUETTANT CONCENTRATE FOR SOLUTION FOR INFUSION 10 MCG/ML
[SIN16847P]
Product information
Active Ingredient and Strength | SODIUM SELENITE EQV TO SELENIUM - 10 MCG/ML |
Dosage Form | INFUSION, SOLUTION CONCENTRATE |
Manufacturer and Country | LABORATOIRE AGUETTANT - FRANCE |
Registration Number | SIN16847P |
Licence Holder | INTEGA PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | A12CE02 |
4.1. Therapeutic indications
Selenium supplementation during parenteral nutrition.
Treatment of selenium deficiency which cannot be compensated by nutrition.
4.2. Posology and method of administration
Posology
1 ml of solution contains 10 micrograms of selenium.
The dose must be adjusted according to the needs of the patient.
The recommended dosage is:
Adults:
Total parenteral nutrition: 60 to 100 micrograms daily.
Selenium deficiency: 100 micrograms (up to a maximum of 400 micrograms) daily for a short period until normalisation of laboratory tests.
Paediatric population:
Total parenteral nutrition:
Infants: 2 micrograms/kg/day and infants with low birth weight: 2 to 3 micrograms/kg/day.
Children: 2 to 3 micrograms/kg/day, up to a maximum of 30 micrograms daily.
Adolescents: no data are available.
Selenium deficiency: no data are available
Selenium serum levels must be monitored regularly (every 6 to 12 months) in long-term parenteral nutrition and in case of renal impairment or more frequently in case of clinical signs of deficiency.
The dose must be adjusted to each individual as a function of the selenium deficiency and the selenium status.
Method of administration
Administration by intravenous route:
SELENIUM AGUETTANT concentrate for solution for infusion 10 micrograms/ml must be administered after dilution in solution for parenteral nutrition, after the stability has been validated, or in an isotonic solution (such as 0.9% sodium chloride or 5% glucose) with a slow infusion rate.
4.3. Contraindications
Hypersensitivity to the active substance
